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Lesions of basal forebrain cholinergic neurons by intracerebroventricular (i.c.v.) injections of 192 IgG-saporin increased the locomotor
response to 0.5 and 1.5 mg/kg of d-amphetamine in adult rats [A. Mattsson, S.O. OVVgren, L. Olson, Facilitation of dopamine_mediated
locomotor activity in adult rats following cholinergic denervation, Exp Neurol. 174 (2002) 96–108.]. In the present study, adult male rats
were subjected to bilateral injections of 192 IgG-saporin either into the septum (Sp), the nucleus basalis magnocellularis (Nbm), both
structures (SpNbm) or i.c.v. Locomotor activity was assessed in the home cage 23 days after surgery, and, subsequently, thrice after an
intraperitoneal injection of d-amphetamine (1 mg/kg) and twice after an injection of cocaine (15 mg/kg). Analysis of AChE-stained material
showed that Sp lesions induced preferentially hippocampal denervation, Nbm lesions induced preferentially cortical denervation, while both
SpNbm and i.c.v. lesions deprived the hippocampus and the cortex of almost all AChE-positive reaction products. The spontaneous and drug-
induced locomotor activity of all lesioned rats did not differ significantly from that of control rats, except in rats subjected to i.c.v. injections,
in which the locomotor response was significantly increased after the second administration of cocaine. In addition, in Nbm and SpNbm rats,
the locomotor reaction to cocaine was weaker right after the second injection. The present results do not confirm the report by Mattsson et al.
on the potentiation of amphetamine-induced locomotion by i.c.v. injections of 192 IgG-saporin, but suggest that cocaine-induced locomotion
can be increased by such lesions and, to some respect, attenuated by cholinergic damage in the Nbm.
D 2004 Elsevier B.V. All rights reserved.
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Besides other cognitive perturbations (e.g., Ref. [7]),
damage to, or extensive denervation of, the hippocampus
usually results in locomotor hyperactivity (e.g., Refs.
[8,9,42,44,48]). This hyperactivity is often interpreted as
resulting from the disruption of an inhibitory control exerted
by the hippocampus on the dopaminergic tone in the0006-8993/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.brainres.2004.09.053
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(J.-C. Cassel).nucleus accumbens. When the hippocampus is damaged,
its inhibitory influence decreases, the dopamine activity
raises and motility increases. This mechanism might also be
involved in hippocampal or fimbria-fornix lesion-induced
potentiation of the hyperlocomotion elicited by amphet-
amine (e.g., Refs. [2,9,28,42]).
The role of hippocampal afferents, as for example
serotonergic or cholinergic ones (e.g., Ref. [7]), in the
locomotor reactivity to amphetamine has been previously
addressed. Balse et al. [2] reported that intrahippocampal
grafts rich in serotonergic neurons reduced the potentia-
tion of amphetamine-induced hyperlocomotion after aspi-
ration of the fimbria-fornix pathways. While locomotor(2004) 259–271
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5,7-dihydroxytryptamine into the cerebral ventricles [28]
or the fimbria-fornix/cingular bundle [25], Asin and
Fibiger [1] reported that 5,7-DHT injected into the median
raphe moderately potentiated amphetamine-induced hyper-
locomotion. In a recent article, Mattsson et al. [29] found
that lesions of the cholinergic basal forebrain by intra-
cerebroventricular injections of the immunotoxin 192 IgG-
saporin in adult rats also induced a dramatic increase of
the locomotor response to amphetamine, suggesting that
such lesions may interact with catecholaminergic mecha-
nisms. The authors attributed this effect to extensive
cholinergic denervation of the hippocampus and the cortex
and discussed it in relation with a possible role of
cholinergic dysfunctioning in schizophrenia. However, the
experimental approach of Mattsson et al. did not allow to
determine whether the observed effects were due to a
lesion of the cholinergic neurons in the nucleus basalis
magnocellularis (Nbm), in the septal region (Sp), or to a
combination of both lesions. Furthermore, as the immu-
notoxin was injected into the lateral ventricles, and thus
could damage cerebellar Purkinje neurons (e.g., Ref. [41]),
possible contribution of the latter alterations could not be
excluded. In the present study, which was underway in a
preliminary form (only septal lesion versus sham oper-
ations) when the article by Mattsson et al. [29] came out,
we tested the locomotor effects of both amphetamine and
cocaine in rats subjected to different types of selective
cholinergic lesions; they were performed by injection of
192 IgG-saporin into the Sp or the Nbm, into both
structures at once, or into the cerebral ventricles.2. Materials and methods
2.1. Subjects
Procedures involving animals and their care were
conducted in conformity with the institutional guidelines
that are in compliance with national (council directive
#87848, October 19, 1987, Ministe`re de l’Agriculture et
de la Foreˆt, Service Ve´te´rinaire de la Sante´ et de la
Protection Animales; authorization #67-14 bis to H.J.,
#6212 to J-C.C., #67-191 to R.G.; C.L. and B.C. under
the responsibility of J-C.C.) and international (NIH
publication no. 86-23, revised 1985) laws and policies.
All efforts were made to minimise both suffering and the
number of animals used.
The study was performed on 63 male Long–Evans rats
(R. Janvier, Le Genest St-Isle, France). At approximately
90 days of age (body weight approximately 300 g), the
rats were allocated to one of five experimental groups, the
group of control rats being constituted of four smaller
subgroups (see below). They received bilateral infusions
of 192 IgG-saporin (Advanced Targeting Systems, San
Diego, USA; batch 24-87) either into the septal region(Group Sp; n=11), the nucleus basalis magnocellularis
(Group Nbm; n=12), both structures (Group SpNbm;
n=12), or the lateral ventricles (Group i.c.v.; n=11). The
rats used as controls (Group Sham; n=16) were subjected
to phosphate-buffered saline injections either into the
septum (n=4), the nucleus basalis (n=4), both structures
(n=4), or the ventricles (n=4). All rats were housed
singly in transparent Makrolon cages (422615 cm)
under a 12:12 h dark–light cycle (lights on at 7h00). The
colony and testing rooms were under controlled tempera-
ture (21 8C) and synchronized dark–light cycles.
2.2. Surgery
All surgical procedures were conducted under aseptic
conditions. The rats were anaesthetised by an i.p. injection of
xylazine 0.85 mg/kg (Rompun 2%, Bayer Pharma, Puteaux,
France) and ketamine 6.38 mg/kg (Imalgene 500, Merial,
Lyon, France), and their eyes were protected against dryness
with a drop of artificial tears fluid (Lacrigel, Europhta,
Monaco, France). Injections of 192 IgG-saporin (1 Ag/Al of
phosphate buffered saline, PBS) or its vehicle were
performed stereotaxically through either a 10-Al (i.c.v.
injections) or a 1-Al (intraparenchymal injections) Hamilton
syringe according to the atlas of Paxinos and Watson [31],
with the incisor bar of the stereotaxic frame set at the level
of the interaural line. Injections into the lateral ventricles
(5.0 Al/rat, i.e., 5.0 Ag 192 IgG-saporin/rat) were performed
at the following coordinates (in mm from Bregma): A 0.8,
L F1.4, V 4.3 (2.5 Al/side). After each injection, the
needle was left in situ for 5 min, retracted 2 mm, and a
second delay of 5 min was allowed before complete
retraction. This procedure was used to minimize aspiration
of the toxin in the track during retraction of the needle. For
bilateral injections into the septal region (0.4 Al/rat, i.e., 0.4
Ag 192 IgG-saporin/rat), the coordinates (in mm from
Bregma) were: A +0.6, L F0.2, V1 7.2 (0.1 Al/side) and
V2 6.5 (0.1 Al/side). After each injection, the needle was
left in situ for 4 min at V1 sites and for 6 min at V2 sites
before being retracted slowly. For the bilateral nucleus
basalis injections (0.4 Al/rat, i.e., 0.4 Ag 192 IgG-saporin/
rat), the coordinates (in mm from Bregma) were: A 1.0,
L F3.0, V 6.5 (0.2 Al/side). After each injection, the
needle was left in situ for 6 min, retracted 1 mm, and a second
delay of 4 min was allowed before complete retraction. The
reason for this two-step retraction was the same as for the
i.c.v. injections. Rats with combined lesions (0.8 Al/rat, i.e.,
0.8 Ag 192 IgG-saporin/rat) received injections into both
structures, with the first injections into the septal region.
2.3. Spontaneous locomotor activity test
Locomotor activity of the rats was measured in the
home cage and all rats were tested at once. The cages
were placed on shelves located in a dedicated room. Each
cage was traversed by two infrared light beams targeted
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apart. The number of cage crossings was recorded by a
microcomputer. The rats, within their home cages, were
introduced into the testing room approximately 15 min
before the session began. Before the start of amphetamine
sessions, 23 days after lesion surgery, spontaneous
locomotor activity was recorded over 24 h (8-h light,
12-h dark, 4-h light). At the end of this session, all rats
remained in the testing room for 5 additional days to
familiarize them with the test conditions.
2.4. Amphetamine-induced locomotor activity
At the end of this 5-day period, locomotor activity of
the rats was determined in their home cages as previously
reported [9]. On days 6 and 8, all rats were given an i.p.
injection of saline (1 ml/kg) about 5–6 min before
recording (from 12h10 to 15h10) in order to habituate
them to the injection procedure. On days 10, 12 and 14,
activity scores were recorded for 3 h after an injection of
d-amphetamine sulfate (1 mg/1 ml saline/kg, i.p.; Sigma,
St. Louis, USA). This dose was used on the basis of our
previous experiments [9,25], but also because it is
between both efficient doses used by Mattsson et al.
[29]. The injection was performed 5–6 min before
recording. On each injection day, the activity scores wereFig. 1. Schematic presentation of all brain areas in which the AChE density was
cortex; CA1: hippocampal field CA1; CA2: hippocampal field CA2; CA3: field
DG: dentate gyrus; Ent: entorhinal cortex; DH: dorsal hippocampus; DLS: dorso
primary and secondary motor cortices; Pir: piriform cortex; PRh: perirhinal corte
cortices; V1–V2: primary and secondary visual cortices; VH: ventral hippocampus
mm from Bregma, the DLS, DMS, VLS and VMS constitute the CPu (according
across sides and antero-posterior coordinates of a given brain region.also measured during the hour preceding the injection as a
within control.
2.5. Cocaine-induced locomotor activity
After a resting period of 7 days during which the rats
were kept in the experimental room, locomotor activity
was again determined in the home cages to evaluate the
effects of cocaine. On day 22, rats were given an i.p.
injection of saline (1 ml/kg) about 5–6 min before
recording was started (from 12h10 to 15h10). On days
24 and 26, activity scores were recorded for 3 h after an
injection of cocaine hydrochloride (15 mg/ml saline/kg,
i.p.; USA). The injection was performed 5–6 min before
recording. On each injection day, the activity scores
were also measured during the hour preceding the
injection.
2.6. Histochemical staining of AChE reaction products
Upon completion of testing, rats were left for a 6-week
period before being injected with an overdose of
pentobarbital (100 mg/kg, i.p.; Sanofi, France) and trans-
cardially perfused with 60 ml of 0.1 M phosphate-
buffered paraformaldehyde (4 8C, pH 8). After extraction,
the brains were post-fixed for about 4 h and transferredmeasured. Ac: accumbens nucleus; Amyg: amygdalar nuclei; Au: auditory
hippocampal CA3; Cg: cingulate cortex; CPu: caudate putamen (striatum);
lateral striatum; DMS: dorsomedial striatum; Ins: Insular cortex; M1–M2:
x; RS: retrosplenial cortex; S1–S2: primary and secondary somatosensory
; VLS: ventrolateral striatum; VMS: ventromedial striatum. Note that at +0.7
to Paxinos and Watson [31]). For data analyses, the values were averaged
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36–40 h. The brains were then quickly frozen using
isopentane (45 8C) and kept at 80 8C until they were
cut into 30-Am-thick coronal sections using a cryostat
(23 8C). From the anterior septum to the posterior
region of the hippocampus, each fifth section was
collected onto gelatine-coated slides. The sections were
dried at room temperature for 36 h and stained for
acetylcholinesterase (AChE) according to a method similar
to that described by Koelle [23]. Ethopropazine (0.3 mM;
Sigma) was used to block nonspecific cholinesterases and
acetylthiocholine iodide (4 mM; Sigma) was used as the
substrate. Although AChE is not considered a highly
specific marker of the cholinergic innervation of the rat
brain, it is well correlated with a more specific cholinergic
marker, namely choline acetyltransferase, at least in theFig. 2. Histochemical staining of AChE. Typical examples of AChE-staining
quantification. Anteriority as well as both the location and the limits of the regions
with Nbm (C), SpNbm (E) or i.c.v. (F) lesions showed almost complete loss of AC
lesions exhibited weaker cholinergic depletion as compared to Sham rats (D). In
Bregma (bottom), the dorsal hippocampus was almost completely deprived of AC
although weaker than in Sham rats (J), the staining was still important in Nbm ra
IgG-saporin injection into the septal region; Nbm: 192 IgG-saporin injection into
both structures; i.c.v.: 192 IgG-saporin injection into the lateral ventricles.hippocampus and the cortex [21,34]. About half of the
sections were stained with cresyl violet [36].
2.7. Histological quantification
The extent of cholinergic denervation, expressed as a
depletion of the density of AChE-positive reaction products,
was determined in various brain regions (see Fig. 1) using a
computer-assisted image analysis system (SAMBA Tech-
nologies, France) that enables measurement of the optical
density (O.D.). The mean O.D. was measured on digitalized
images after precise delineation of each brain region of
interest. A total of 30 measures from each hemisphere were
taken on four sections in various cortical and subcortical
zones at +0.7, 1.4, 3.6 and 5.8 mm from Bregma [31].
The mean O.D. considered as a bbackgroundQ and sub-density patterns at two antero-posterior levels used for histochemical
photographed are indicated in A and G At +0.7 mm from Bregma (top), rats
hE-positive staining density in this cortical region, whereas rats with Sp (B)
serts are portions of each cortex magnified five times. At 3.6 mm from
hE-positive histochemical products in Sp (H), SpNbm (K) or i.c.v. rats (L);
ts (I). Scale bar, 1 mm. Abbreviations: Sham : sham-operated rats; Sp: 192
the nucleus basalis magnocellularis; SpNbm: 192 IgG-saporin injection into
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the material of lesioned rats where absolutely no AChE
reaction products could be seen under a microscope and
where the lowest O.D. was calculated by the computer. This
background value was the mean computed from measure-
ments made on 20 different sections. The experimenter
performing the O.D. assessments was not aware of the rat’s
surgical treatment, but could see which rat was lesioned and
which one was not.
2.8. Statistical analysis
Locomotor data as well as mean AChE-staining density
indexes were analysed with analysis of variance (ANOVA)
followed, where appropriate, by 22 comparisons based on
the Newman–Keuls multiple range test [45]. Rats with
asymmetric or insufficient lesions were discarded from all
analysis: They were three Sp, two Nbm and two SpNbm
rats. Due to a technical failure, no reliable histological
material was obtained from one of the sham-operated rats
which was also discarded from analysis. After verifications
for possible bsideQ effects, O.D. values from the left and the
right hemispheres were averaged with respect of the brain
region to which they corresponded. In addition, values from
each brain region were averaged across levels of anteriority,
in order to obtain one average value per brain region.
Analysis was performed on these average values according
to a Lesion (Sham, Sp, Nbm, SpNbm, i.c.v.)Region
(cingulate cortex, motor cortex. . .) design.
As rats generally show increased levels of activity that
may be linked to the novelty of the experimental situationTable 1
Mean O.D. (arbitrary units) of AChE-positive staining in various brain structures
Brain structures AChE-positive staining density
Sham Sp
Cingulate cortex 13.25F1.04 4.43F0.51*
Motor cortex (M1, M2) 9.12F0.74 5.37F0.64*
Somatosensory cortex (S1) 8.16F0.69 6.99F0.68
Insular cortex (granular,
dysgranular, agranular)
11.76F0.87 10.96F0.76
Dorsomedial striatum 53.12F1.68 55.82F1.85
Dorsolateral striatum 67.10F1.85 68.51F1.61
Ventromedial striatum 66.83F2.27 68.18F1.55
Ventrolateral striatum 57.43F1.90 58.53F1.73
Nucleus accumbens 47.04F1.74 47.50F1.94
Piriform cortex 18.94F1.32 16.01F0.81
Caudate putamen 54.37F1.83 54.09F1.84
Retrosplenial cortex
(granular, agranular)
9.79F0.90 2.69F0.42*
Auditory and perirhinal cortices 8.75F0.68 8.16F0.89
Amygdala 18.24F1.40 16.05F0.94
Dorsal hippocampus 16.35F0.79 3.28F0.66*
Ventral hippocampus 17.44F0.82 3.81F0.80*
Visual cortex (V1, V2) 6.51F0.60 4.27F0.67*
Entorhinal cortex 12.54F1.08 10.95F0.86
Data are presented as meanFS.E.M. Effects of 192 IgG-saporin injections into
structures (SpNbm), or the lateral ventricles (i.c.v.). Statistics: *significantly diffeduring the first hours right after their introduction into the
new experimental room, the three first hours of recording
(habituation period) were analysed separately from the other
activity scores. This analysis considered factors Lesion
(Sham, Sp, Nbm, SpNbm, i.c.v.) and Hour (1, 2, 3) and was
performed on data recorded 23 days after surgery. The
remaining diurnal or nocturnal activity scores were con-
verted to an average number of cage crossings per hour and
analysed according to a LesionDay period (diurnal,
nocturnal) design. Before starting the amphetamine injec-
tions, rats were given NaCl injections on two occasions.
Activity scores recorded after these injections were averaged
to generate one series of control values in each group. Thus,
analyses of the activity scores recorded under amphetamine,
cocaine or control treatments used a Lesion (Sham, Sp,
Nbm, SpNbm, i.c.v.)Drug (NaCl, Amph1, Amph2,
Amph3 or NaCl, Cocaine 1, Cocaine 2)Hour (1, 2, 3)
design. Regression analyses between denervation extents
and locomotor responses to the drugs were also performed
(Pearson’s correlation). Sham-operated rats were not con-
sidered in these analyses.3. Results
3.1. Histology and histochemistry
On most sections collected in the vicinity of the injection
points, the needle tracks could be clearly identified.
Inspection of these sections, whether stained with cresyl
violet or for AChE-histochemistry, did not show any sign ofNbm SpNbm i.c.v.
9.32F0.59*# 3.61F0.49*§ 3.01F0.35*§
3.65F0.50*# 1.80F0.41*#§ 0.71F0.15*#§
2.44F0.50*# 2.23F0.49*# 1.02F0.21*#
9.39F0.82 7.63F0.49*# 5.04F0.50*#§$
50.87F1.74 52.79F2.06 56.16F2.29
62.73F1.65 66.01F2.18 68.85F1.85
61.92F1.72 66.56F1.79 70.42F2.04
53.63F1.76 56.39F2.03 59.63F2.37
42.19F1.73 45.21F2.21 47.48F2.91
15.60F0.86 13.26F0.79* 6.66F0.80*#§$
46.91F1.85*# 50.35F1.28 53.96F1.86§
7.55F0.59*# 2.49F0.46*§ 2.39F0.26*§
5.45F0.70*# 4.81F0.61*# 2.20F0.33*#§$
14.68F0.81 12.95F0.85* 11.69F0.89*#
11.21F1.79*# 2.28F0.42*§ 4.24F0.79*§
10.94F1.90*# 1.50F0.29*§ 3.86F0.64*§
3.30F0.57* 1.60F0.45*#§ 0.37F0.11*#§
10.42F0.86 8.07F0.71* 5.28F0.84*#§$
the septal region (Sp), the nucleus basalis magnocellularis (Nbm), both
rent vs. Sham; #vs. Sp; §vs. Nbm; $vs. SpNbm rats ( pb0.05 at least).
Fig. 3. Hourly locomotor activity scores (+S.E.M.) during the habituation
(A), the diurnal (B) and the nocturnal (C) period of recording. Group
abbreviations as in Fig. 2.
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injections. In rats given i.c.v. injections of 192 IgG-saporin,
there was some ventricular enlargement.
Examples of AChE-positive staining patterns are shown
in Fig. 2. The intraseptal injection of 192 IgG-saporin
induced a strong depletion of AChE-positive reaction
products in the cornu ammonis (CA1–CA3) and the dentate
gyrus. A reduced AChE-positivity was also found in cortical
regions, particularly in areas 1 and 2 of the frontal cortex, in
the posterior part of the parietal cortex, and in the occipital
(area 2) cortex (data not illustrated). The intrabasalis
injection of 192 IgG-saporin induced the most severe
denervation in the motor and somatosensory cortices, while
weaker effects were found in the hippocampus. When both
lesions were combined, their effects roughly corresponded
to a combination of the depletion produced by each single
lesion (see Table 1 for more details). Intracerebroventricular
injections of the immunotoxin resulted in a severe decrease
of AChE-positive reaction products in all cortical regions
assessed, as well as in the hippocampus. There was no
evidence for depletion of AChE-positive reaction products
in the striatum (caudate/putamen and nucleus accumbens). It
is also noteworthy that the variability across subjects was
extremely small in the different Lesion groups. All these
observations were confirmed, and even refined, by densito-
metric, and thus quantitative, analyses.
3.2. Densitometry
Table 1 provides a detailed overview of the mean
(FS.E.M.) values found in each brain area assessed.
Regarding the number of regions considered and of
comparisons made, the statistical details indicated in Table
1 are only briefly mentioned in this part of the text. ANOVA
showed a significant Lesion effect [F(4,50)=6.7, Pb0.001]),
a significant Region effect [F(17,850)=3091.1, Pb0.001],
and a significant interaction between both factors
[F(68,850)=9.1, Pb0.001]. Compared to Sham rats, Sp rats
showed a significantly decreased O.D. in the cingulate,
motor, retrosplenial and visual cortices, as well as in the
dorsal and the ventral hippocampus (Pb0.05). In Nbm rats,
O.D. reduction was significant in the cingulate, motor,
somatosensory, retrosplenial, auditory, perirhinal and visual
cortices, but also in the caudate putamen, as well as in the
dorsal and ventral hippocampus (Pb0.05). It is noteworthy,
however, that in the hippocampus, the reduction was
significantly less pronounced in Nbm than in Sp rats
(Pb0.05). SpNbm rats showed decreases of AChE densities
which roughly corresponded to a combination of the
depletions found in Sp and Nbm rats; in the cingulate,
motor, retrosplenial and visual cortices, as well as in the
dorsal and ventral hippocampus, however, the decrease of
AChE-staining was significantly larger than in the Nbm rats
(Pb0.05). Finally, i.c.v. rats showed a decrease of AChE
densities often corresponding to the ones found in SpNbm.
However, in the insular, piriform, perirhinal and entorhinalcortex, the cholinergic depletion was significantly larger in
i.c.v. than in SpNbm rats (Pb0.05).
3.3. Locomotor activity, no drug
Data are shown in Fig. 3. ANOVA of the activity
scores recorded during the three first hours (habituation
period) showed only a significant effect of the factor Hour
[F(2, 100)=92.04, Pb0.001], which can be explained by
an overall activity that was significantly higher during the
first hour as compared to the second or third one
(Pb0.001 in each case). There was no significant Lesion
effect [F(4,50)b1.0] and no significant LesionHour
interaction [F(8,100)b1.0].
ANOVA of the diurnal and the nocturnal activity scores
showed no significant Lesion effect [F(1,50)b1.0], a
significant Day period effect [F(2,100)=92.0, Pb0.001],
but no significant interaction between both factors
[F(8,100)b1.0]. The Day period effect was due to overall
H. Jeltsch et al. / Brain Research 1029 (2004) 259–271 265activity scores that were significantly higher during the
night as compared to the day.
3.4. Locomotor activity after amphetamine injections
Locomotor scores were recorded during 3 h after the
injection, but also during the hour right before injection.
During this hour, there was only a significant Drug effect
[F(4,200)=5.28, Pb0.001], but neither a significant Lesion
effect [F(4, 50)=0.46, P=0.76], nor a significant interaction
between both factors [F(16,200)=0.91, P=0.55; data not
illustrated]. The Drug effect was due to overall activity
levels which were slightly, though significantly higher on
the Amphet 2 day as compared to either of the three other
days (NaCl, Amphet 1 and Amphet 3; Pb0.005 in all cases).
Data of the activity scores recorded after the injection are
shown in Fig. 4. ANOVA showed no significant Lesion effect
[F(4,50)b1.0], but there was a significant Drug effect
[F(3,150)=32.3, Pb0.001], and a significant Hour effect
[F(2,100)=90.0, Pb0.001]. In addition, there was also a
significant DrugHour interaction [ F (6,300)=23.8,
Pb0.001]. All other interactions failed to reach significance.
The Drug effect was due to overall activity scores that were
significantly higher after amphetamine injections as com-
pared to NaCl, whatever injection day was considered
(Pb0.001). Also, the overall activity scores were larger after
the second and third day of amphetamine injection as
compared to the first one (Pb0.01). The Hour effect was
due to overall activity scores that were significantly smaller
during the second and the third hours as compared to the first
one (Pb0.001). In addition, during the third hour, the activity
was significantly smaller than during the second one
(Pb0.001). Finally, the DrugHour interaction can beFig. 4. Hourly locomotor activity scores (+S.E.M.) during each of the three hours (
averaged across days 6 and 8 of the experiment; see Materials and methods), or of a
2) and 14 (Amphet 3). Group abbreviations as in Fig. 2. For detailed statistics, sinterpreted as reflecting the large reduction between hours 1
and 2, but also 2 and 3 after amphetamine treatment as
compared to the weaker reduction observed after NaCl
injection.
In summary, it appears that none of the cholinergic
lesions significantly altered the locomotor responsiveness to
amphetamine.
3.5. Locomotor activity after cocaine injections
During the hour preceding the injection, there was only a
significant Drug effect [F(2,100)=6.56, Pb0.01]; the Lesion
effect [F(4,50)=1.09, P=0.36] and the LesionDrug inter-
action [F(8,100)=1.07, P=0.38] were not significant (data
not illustrated). The Drug effect was due to overall activity
levels which were significantly higher on Cocaine 1 and
Cocaine 2 days as compared to the NaCl day (Pb0.01 in all
cases). Data of the activity scores recorded after the injection
are shown in Fig. 5. ANOVA showed no significant Lesion
effect [F(4,50)=1.4], but all other effects of single factors
or interactions were significant: Drug [F(2,100)=59.3,
Pb0.001], Hour [F(2,100)=148.8, Pb0.001], LesionDrug
[F(8,100)=2.5, Pb0.05], LesionHour [F(8,100)=3.4,
Pb0.01], DrugHour [F(4,200)=20.4, Pb0.001], Lesion
DrugHour [F(16,200)=3.1, Pb0.001]. The Drug effect was
due to overall activity scores that were significantly higher
after cocaine injections as compared to NaCl, regardless of
the injection day (Pb0.001). Scores after the first and the
second cocaine injections did not differ significantly from
each other. The Hour effect was due to overall activity scores
that were significantly smaller during the second and the third
hours as compared to the first one (Pb0.001). In addition,
during the third hour, the activity was significantly lower thanHour 1, Hour 2, Hour 3) following the injection of NaCl (1 ml/kg; i.p.; data
mphetamine (1 mg/1 ml saline/kg; i.p.) on days 10 (Amphet 1), 12 (Amphet
ee Results.
Fig. 5. Hourly locomotor activity scores (+S.E.M.) during each of the three hours (Hour 1, Hour 2, Hour 3) following the injection of NaCl (1 ml/kg; i.p.) on
days 22 of the experiment (see Materials and methods), or of cocaine (15 mg/1 ml saline/kg; i.p.) on days 24 (Cocaine 1) and 26 (Cocaine 2). Group
abbreviations as in Fig. 2. For detailed statistics, see Results.
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action was due to significantly increased scores in Nbm rats
after the first injection of cocaine as compared to saline, but
not after the second one; conversely, in all other groups, the
activity scores after the first and the second injections were
significantly larger than after saline injection (Pb0.05). The
LesionHour interaction was due to overall activity scores
that were significantly higher during the first hour in i.c.v. rats
as compared to their sham-operated counterparts, but also to
all other lesion groups; in contrast, during the second and the
third hour, there was no significant difference between the six
treatment groups. The DrugHour interaction could reflect
the large reduction of overall activity scores between hours 1
and 2, but also 2 and 3, after cocaine treatment, as compared
to the weaker reduction after NaCl injection. Finally, the
LesionDayHour interaction was due to significantly
weaker activity scores in Nbm and SpNbm rats during the
first hour of day 3, as compared to the first hour of day 2,
whereas in i.c.v. rats activity scores were significantly higher
on day 3 (Pb0.01), and in both Sham and Sp rats they were
not significantly changed. During the second and the third
hour, all these differences disappeared.
In summary, whereas the lesions did not alter the overall
activity scores, i.c.v. rats showed a larger increase of activity
during the first hour after the second day of cocaine
injection, whereas Nbm and SpNbm rats exhibited a weaker
response.
3.6. Regression analyses
These analyses, which did not consider the sham-
operated rats, were performed in order to establish if there
was a correlation between the extent of the lesions in eachbrain region and the locomotor response to amphetamine
or cocaine. The only significant correlations found were
between: (i) activity during the second hour after the third
saline injection and AChE staining in the cingular
(R=0.36, Pb0.05) and retrosplenial cortex (R=0.36,
Pb0.05), (ii) activity scores during the third hour after the
first cocaine injection and AChE staining in the insular
cortex (R=0.36, Pb0.05), the dorsomedial (R=0.37,
Pb0.05), dorsolateral (R=0.43, Pb0.01), ventromedial
R=0.43, Pb0.01), ventrolateral (R=0.44, Pb0.01) stria-
tum, nucleus accumbens (R=0.44, Pb0.01) and caudate
putamen (R=0.34, Pb0.05), as well as visual (R=0.52,
Pb0.001) and entorhinal cortices (R=0.36, Pb0.05); (iii)
activity scores during the first hour after the second
cocaine injection and AChE staining in the motor (R=0.46,
Pb0.01), somatosensory (R=0.39, Pb0.05), insular
(R=0.40, Pb0.05), piriform (R=0.39, Pb0.05), auditory
and perirhinal (R=0.43, Pb0.01) cortices, as well as in the
amygdala (R=0.34, Pb0.05). In summary, these analysis
did not enable to establish a clear correlation between the
lesion extent and the locomotor responses to either
psychostimulant. This conclusion is strengthened by the
fact that when each lesion group was considered sepa-
rately, almost all these correlations failed to be significant.4. Discussion
Our histological data confirmed that injections of 192
IgG-saporin into the rat brain produced cholinergic dener-
vation of cortical and hippocampal structures, and that the
extent of this denervation in various cholinergic targets
depended on the injection site of the toxin. Optical density
H. Jeltsch et al. / Brain Research 1029 (2004) 259–271 267measures showed that after intraseptal injections of the
toxin, the AChE-staining was reduced by about 70% in the
cingulate and retrosplenial cortices, about 80% to 90% in
the hippocampus, and by about 30% in most cortical
territories. After injections into the Nbm, reductions of
AChE-staining of up to 70% were found in the neocortex,
but they did not exceed 40% in the hippocampus. When
both nuclei were damaged concomitantly by intraparenchy-
mal (SpNbm) or intraventricular (i.c.v.) injections of the
immunotoxin, dramatic reductions of AChE-staining were
found in both the neocortex and the hippocampus. Given the
partial cortical denervation found in Sp rats and the partial
hippocampal denervation found in Nbm rats, and although
these alterations were not as pronounced as in SpNbm rats,
it seems that some diffusion of the toxin has occurred from
one nucleus to the other one. This point was recently
discussed by Lehmann et al. [27]. Despite these dramatic
cholinergic changes in the target structures of the basal
forebrain, the locomotor response to d-amphetamine was
altered in none of the four lesion groups. This finding seems
at variance with the recent report by Mattsson et al. [29]. In
the present study, after the second injection, the cocaine-
induced hyperactivity was larger in rats given the toxin
intracerebroventricularly, and smaller in those subjected to
Nbm lesions, as compared to the activity found after the first
injection.
The massive reduction of the AChE-positive reaction
products in the hippocampus confirms previous reports
showing that intraseptal, intra-Nbm or intracerebroventric-
ular injections of 192 IgG-saporin massively and selectively
deprive the hippocampus and/or the cortex of its cholinergic
afferents from the basal forebrain (e.g., Ref. [49], for a
review; see also Refs. [25,26]).
Previous studies based on such injections showed
weak or no effects on locomotor activity (e.g., Refs.
[14,24,26,27,25,39,41]). When observed, the weak hyper-
activity concerned the nocturnal phase of the nycthemeral
cycle [32,39] or occurred in response to novelty [39]. It is
noteworthy, nevertheless, that Mattsson et al. [29] also
reported a diurnal hyperactivity induced by i.c.v. injections
of 192 IgG-saporin, although this hyperactivity was not very
marked and was probably reflecting a slower habituation to
the test conditions, as it was only observed during the first
30 min of testing.
Previous experiments have shown that repeated injec-
tions of amphetamine or cocaine may, under some
conditions, elicit sensitization. Sensitization, which corre-
sponds to an increased response to a repeated treatment
with a constant dose of a psychostimulant drug [47], was
also found in the present experiment, but only over trials
where rats were given amphetamine (Amphet 3 vs.
Amphet 1 in Fig. 4). The fact that the overall response
to cocaine after the second injection was not larger than
after the first one can be linked to data which
demonstrated that cross-sensitization may occur between
amphetamine and cocaine (e.g., Ref. [46]).Due to possible cross-sensitization, the interpretation of
the lesioncocaine interaction is difficult. It is noteworthy,
however, that despite a possible influence of cross-sensiti-
zation, rats subjected to either i.c.v. or Nbm lesions showed
relative response changes in opposite directions from the
first to the second cocaine injection days. Such opposite
modifications cannot only be explained by an interaction
between the lesion and cross-sensitization phenomena.
The major contribution of the present study concerns the
lack of significant potentiation of amphetamine-induced
hyperactivity in rats subjected to 192 IgG-saporin lesions. In
their report, Mattsson et al. [29] postulated that the hyper-
responsiveness to amphetamine found after i.c.v. injections
of 192 IgG-saporin was due to the lesion of cholinergic
neurons in the basal forebrain. They concluded that bsevere
cholinergic deficiencies in the forebrain can lead to
dopaminergic overfunctionQ. Table 1 and Figs. 3 and 4
may seem to show that after cortical denervation (i.e., in
i.c.v., Nbm and SpNbm rats), the activity levels and
responses to amphetamine are larger than in Sham and Sp
rats. This would be in line with the data reported by
Mattsson et al. [29], but it was not substantiated by our
statistical analyses. Thus, our present data on the effects of
amphetamine after cholinergic lesions do not support the
conclusion drawn by Mattsson et al. [29]. This contradiction
deserves several remarks.
First, the lack of cholinergic denervation-induced poten-
tiation of the locomotor response to amphetamine in the
present study was not due to an insufficient dose of
amphetamine (1 mg/kg). Indeed, Mattsson et al. also
observed a lesion-induced potentiation at the dose of 0.5
mg/kg [29]. Conversely, it might be possible that lesion-
induced differences in the locomotor sensitivity to amphet-
amine have been masked by a ceiling effect of a too large
dose. Two arguments can be opposed to such a possibility:
the dose used in the present study (1 mg/kg, i.p.) is not
considered maximal in the literature, and, in comparison
with some of our previous studies based on the same
behavioral evaluations (e.g., Ref. [2]), locomotor activity
could further increase. However, as we only have used one
dose of each drug, the possibility that other doses may have
produced different results cannot be ruled out.
Second, Mattsson et al. tested their rats (adult lesions)
about 8–9 months after surgery, a rather long post-surgical
delay. Interestingly, Perry et al. [32] reported that, after a
long post-surgical delay (11 months), 192 IgG-saporin-
induced lesions could be accompanied by nonselective
damage (see also [39]). It should nevertheless be noticed
that these authors injected the toxin directly into the basal
forebrain, while Mattsson et al. injected it into the lateral
ventricles [29]. Whether such nonselective damage may also
appear after i.c.v. administrations of 192 IgG-saporin and
whether it may interfer with the responsiveness to amphet-
amine remain to be determined. In addition, it is worth
mentioning that Mattsson et al. did not report on such
unusual damage in their study [29].
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cholinergic lesions in neonates and adult rats and found
that potentiation of the response to amphetamine was only
seen in adults [29]. Interestingly, a major difference between
neonatal and adult lesions in their experiment was that adult
lesions also altered Purkinje neurons in the cerebellum, a
well-documented fact after i.c.v. administration of 192 IgG-
saporin (e.g., Ref. [41]), whereas neonatal lesions did not.
Thus, lesions of the Purkinje cells might account for the
amphetamine-induced effects reported by Mattsson et al. in
adult rats [29]. Our present results in i.c.v. rats, in which the
effects of 192 IgG-saporin on AChE-positivity were the
largest, do not support this hypothesis. We did not assess the
extent of Purkinje cells in the present experiment but, with
the amount of 192 IgG-saporin injected into the cerebral
ventricles, it is clear that such damage may have been
present. A new experiment based on specific lesions of
Purkinje neurons (by OX7-saporin; see Ref. [43]) would
certainly be the most appropriate way to address the
question of an interaction of such lesions with amphet-
amine-induced hyperlocomotion.
Fourth, the possibility of differences in the lesion extent
between both studies should also be discussed briefly.
Indeed, it cannot be excluded that the effects reported by
Mattsson et al. [29] were linked to more extensive
cholinergic damage than in our present study. However, it
appears that the lesion extents were probably quite
comparable among i.c.v. rats of both experiments, as
Mattsson et al. reported on (and illustrated) an almost
complete loss of AChE-positive fibers in the hippocampus,
the frontal and parietal cortices, while some fibers were
preserved in the perirhinal cortex [29]. This is exactly what
we found in our rats subjected to i.c.v. injections of the
toxin. Unfortunately, the comparison can only be based on
qualitative aspects, as Mattsson et al. did not quantify the
lesion extent. From our quantitative data, it appears that the
maximal reduction of the O.D. amounted 90%, which might
indicate that the lesions were not total. However, this 90%
reduction corresponded to brain regions where no AChE-
positive reaction products could be found at all (see Fig. 2E,
F, K, L), suggesting that the blank value that we used was
smaller than the background devoid of AChE reaction
products, and thus that our quantitative approach probably
underestimated the lesion extent.
Another indirect argument is provided by our regression
analysis on the extent of the AChE-positive denervation and
the locomotor response to the drugs: no clear or consistent
correlation could be evidenced. Nevertheless, it cannot be
ruled out that differences in the quality of the respective
lesions accounted for the failure to replicate the results
reported by Mattsson et al. [29]. If so, one would have to
consider that the lesion-induced potentiation of the loco-
motor response to amphetamine can be evidenced only after
complete cholinergic damage.
Fifth, locomotor activity was assessed under as calm as
possible circumstances in the present experiment, with onlytwo light beams, one at each cage extremity, 28 cm apart.
Such a design did not enable the detection of short walks
and other small movements (e.g., motility), which were
recorded by Mattsson et al. [29]. However, the latter authors
also found potentiation of amphetamine-induced locomo-
tion based on movements of at least 32 cm. This means that
our design does not account alone for the discrepancy
between both studies.
Another possibility concerns the level of familiarization
with the test apparatus/conditions. In the present study, the
testing environment was very familiar. This is at variance
with the study by Mattsson et al. [29] who used relatively
novel conditions. It is well known that environmental
novelty may alter arousal and attention levels [3], which
both are under the control of basal forebrain cholinergic
neurons [11]. Furthermore, environmental novelty influen-
ces the behavioral effects of psychostimulants as recently
reported [13,30,40].
Therefore, it is possible that the data reported by
Mattsson et al. reflected a complex interaction between
the cholinergic lesion in the basal forebrain, the novelty-
driven changes in attention and arousal, and the effects of
the psychostimulants on the monoaminergic systems. On the
contrary, it can be proposed that our testing conditions have
prevented such an interaction due to high levels of
familiarization.
Finally, Mattsson et al. have performed their experiment
on female rats, whereas we have used males. A difference
between males and females on the response to amphetamine
injections is found mostly on the amplitude of the intra-
group variability, males showing a much higher variability
than females [6]. Increasing the group sizes might be a
possible way to ameliorate the statistical power of our
approach. Interestingly, there may exist a sexual dimor-
phism in the responsiveness of dopaminergic systems of the
midbrain to various types of drugs such as, for instance,
cocaine or d-amphetamine (e.g., Refs. [4,5]), or dopami-
nergic ligands [18,35]. Whether such a dimorphism might
account for differential responsiveness to dopaminergic
drugs after cholinergic lesions in the basal forebrain remains
to be determined.
There is evidence, however, that the cholinergic drug
nicotine produces larger locomotor effects in females than
in males [12]. In a currently running experiment,
preliminary data suggest that cholinergic lesions compa-
rable to the present ones induce hyperactivity in females,
at least during the nocturnal phase of the cycle. Therefore,
whether part of the variability in the locomotor effects of
192 IgG-saporin lesions might be linked to sex-dependent
factors remains to be determined. This question would
deserve a separate experiment, as would also that of
possible strain differences. Indeed, the present study was
carried out on Long–Evans rats and on Sprague–Dawley
rats in the study of Mattsson et al. [29], and genetic
variability may also modulate the effects of psychostimu-
lant drugs (e.g., Ref. [38]).
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cholinergic lesions induced by 192 IgG-saporin were shown
to interact with central dopaminergic processes, and this
interaction may have locomotor correlates. Previous studies
have shown that lesions of the cholinergic interneurons in
the nucleus accumbens potentiated the responsiveness to
cocaine, at least in mice [20], and mice lacking muscarinic
receptors are more sensitive to psychostimulant drugs (e.g.,
Refs. [15,37]). In the present study, when rats were treated
with cocaine, a compound which is more selective for
dopaminergic neurons than amphetamine, we could even-
tually observe a potentiated locomotor response in the
animals subjected to i.c.v. administration of the immuno-
toxin. However, as this potentiation was not found in the
three other lesion groups (and there was even some decrease
in rats with Nbm lesions), our data must be considered with
some caution. In addition, there was no sign of cholinergic
lesions in the nucleus accumbens of our rats, an observation
that can be explained by the fact that the expression of
p75NTR receptors by such interneurons is weak in adult rats
(e.g., Ref. [41]). It is nevertheless worth mentioning that,
when compared to the effects of SpNbm lesions, i.c.v.
lesions produced a larger reduction of AChE-positivity in
the insular, the piriform, the auditory, the perirhinal and the
entorhinal cortices. Whether a cholinergic denervation of
one or more of these structures might have contributed to
the increased locomotor response to cocaine would certainly
require further experimentation.
A final observation deserving discussion is the fact
that after the second cocaine injection, rats with Nbm
lesions, whether combined or not to Sp lesions, showed
a weaker response during the first post-injection hour in
comparison with the previous day. This observation,
which is opposite to the sensitization normally seen in
intact animals, might indicate that lesions of the
cholinergic component of the Nbm interfere with some
aspects of the locomotor response to cocaine. Robledo et
al. [33] reported that rats given the possibility to self-
administer low doses of cocaine, self-injected larger
amounts of this psychostimulant drug following a lesion
of the Nbm induced by intraparenchymal infusions of
alpha-amino-3-hydroxy-5-methyl-isoxazol-4-propionic acid
(AMPA). These results might indicate that cholinergic
neurons of the Nbm can modulate some aspects of cocaine
self-administration, and perhaps of the neuropharmacological
effects of this drug. If so, our data suggest that this modulation
might consist in an attenuation of the behavioral responsive-
ness to cocaine. This issue should be further explored.
In conclusion, the present experiment showed that an
extensive cholinergic denervation of the hippocampus and/
or the cortex by intraseptal and/or intrabasalis, or even
intracerebroventricular injections of 192 IgG-saporin, does
not induce potentiation of the locomotor response to
amphetamine. This is in opposition with the data reported
by Mattsson et al., who illustrated that cholinergic lesions
potentiated the locomotor response to amphetamine [29]. Itis worth mentioning that this opposition might rely upon
differences in the sex and strain of rats used in each study,
perhaps in the respective lesion extents or in the degree of
familiarization with the testing conditions. Based on this
discrepancy, and also on the fact that rats given 192 IgG-
saporin intracerebroventricularly showed exacerbated loco-
motor responses to cocaine, whereas rats with Nbm lesions
showed a reduced response after the second injection of this
drug, it seems prudent to conclude on a need for further
experimentation before establishing a link between an
overreactivity to dopaminergic stimulation resulting from
basal forebrain cholinergic lesions and dysfunction in
schizophrenia. Other approaches, however, seem to indicate
that cholinergic functions may exert an inhibitory influence
on dopaminergic ones. For instance, M1 receptor knock-out
mice, which can be considered as bearing a reduced
postsynaptic cholinergic excitatory potential, show
increased levels of activity and larger locomotor responses
to amphetamine ([15]; see also [10]). This is also the case in
M4 receptor knock-out mice [16]. A muscarinic agonist
such as xanomeline may attenuate the behavioral response
to amphetamine [37], although, another agonist, oxotremor-
ine, may induce sensitization to amphetamine under some
circumstances [17], and a cholinergic input to the substantia
nigra may activate dopaminergic function in the striatum
[19]. Some studies, however, suggest opposite effects of
cholinergic drugs on dopaminergic functions depending on
the brain region considered [22]. A final remark concerns
previous reports showing that lesions in the hippocampal
formation potentiate the locomotor response to amphet-
amine [9]; our data suggest that damage to the cholinergic
subset of the hippocampal circuitry probably does not
participate in this potentiation.Acknowledgements
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